MINAPHARM Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
MINAPHARM Pharmaceuticals has a total shareholder equity of EGP3.5B and total debt of EGP3.6B, which brings its debt-to-equity ratio to 103.1%. Its total assets and total liabilities are EGP8.7B and EGP5.2B respectively. MINAPHARM Pharmaceuticals's EBIT is EGP374.7M making its interest coverage ratio 1.6. It has cash and short-term investments of EGP1.9B.
Key information
103.1%
Debt to equity ratio
ج.م3.63b
Debt
Interest coverage ratio | 1.6x |
Cash | ج.م1.92b |
Equity | ج.م3.52b |
Total liabilities | ج.م5.19b |
Total assets | ج.م8.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MIPH's short term assets (EGP4.0B) exceed its short term liabilities (EGP3.5B).
Long Term Liabilities: MIPH's short term assets (EGP4.0B) exceed its long term liabilities (EGP1.7B).
Debt to Equity History and Analysis
Debt Level: MIPH's net debt to equity ratio (48.5%) is considered high.
Reducing Debt: MIPH's debt to equity ratio has increased from 58.2% to 103.1% over the past 5 years.
Debt Coverage: MIPH's debt is not well covered by operating cash flow (2.9%).
Interest Coverage: MIPH's interest payments on its debt are not well covered by EBIT (1.6x coverage).